Skip to main content
. 2023 Aug 27;49(5):346–354. doi: 10.1136/rapm-2023-104751

Figure 4.

Figure 4

(A) Minimal clinically important improvements observed for each impaired domain at 36-month follow-up. (B) Cumulative responder score at 36-month follow-up. *Statistical significant at p<0.05 level. CL-SCS, closed-loop SCS; MCID, minimal clinically important difference; ODI, Oswestry Disability Index; OL-SCS, open-loop SCS; POMS, Profile of Mood States; PSQI, Pittsburgh Sleep Quality Index; SCS, spinal cord stimulation; TMD, total mood disorder; VAS, Visual Analog Scale.